Nuclear E-cadherin Expression is Associated with the Loss of Membranous E-cadherin, Plasmacytoid Differentiation and Reduced Overall Survival in Urothelial Carcinoma of the Bladder-Reference-Cited by-同舟云学术

Nuclear E-cadherin Expression is Associated with the Loss of Membranous E-cadherin, Plasmacytoid Differentiation and Reduced Overall Survival in Urothelial Carcinoma of the Bladder

Published:2012-10-30 Issue:7 Volume:20 Page:2440-2445
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Keck Bastian,Wach Sven,Kunath Frank,Bertz Simone,Taubert Helge,Lehmann Jan,Stöckle Michael,Wullich Bernd,Hartmann Arndt

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-012-2709-4.pdf

Reference25 articles.

1. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010;46:765–81.

2. Eble J SG, Epstein JI, Sesterhenn IA, editors. Classification of tumours. Pathology and genetics of the tumours of the urinary system and male genital organs. Lyon: World Health Organization; 2004.

3. Bringuier PP, Umbas R, Schaafsma HE, Karthaus HF, Debruyne FM, Schalken JA. Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res. 1993;53:3241–5.

4. Keck B, Stoehr R, Wach S, et al. The plasmacytoid carcinoma of the bladder—rare variant of aggressive urothelial carcinoma. Int J Cancer. 2011;129:346–54.

5. Gamallo C, Palacios J, Suarez A, et al. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol. 1993;142:987–93.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ovarian Clear Cell Carcinoma and Markers of Epithelial-Mesenchymal Transition (EMT): Immunohistochemical Characterization of Tumor Budding;International Journal of Gynecological Pathology;2023-01-10

2. Molecular characterization of plasmacytoid urothelial carcinoma and the impact on treatment implications;Cancer Treatment and Research Communications;2023

3. Plasmacytoid Urothelial Carcinoma of the Bladder That Manifests Disseminated Carcinomatosis of the Bone Marrow: A Case Report of Extremely Rapid Progression;Case Reports in Urology;2022-09-15

4. Molekulare Subtypen des fortgeschrittenen Urothelkarzinoms;Uro-News;2022-03

5. Patient with prostatic adenocarcinoma with plasmacytoid features and an aberrant immunohistochemical phenotype diagnosed by biopsy and a mini‑review of plasmacytoid features in the genitourinary system: A case report;Molecular and Clinical Oncology;2022-01-20